ТОЛЩИНА ИНТИМА-МЕДИА — ПРЕДИКТОР ВЫЯВЛЕНИЯ ИШЕМИЧЕСКОЙ БОЛЕЗНИ СЕРДЦА И НЕЗАВИСИМЫЙ ФАКТОР РИСКА РАЗВИТИЯ СЕРДЕЧНО-СОСУДИСТЫХ СОБЫТИЙ
https://doi.org/10.17650/1818-8338-2011-4-5-9
Аннотация
Толщина интима-медиа (ТИМ) сонных артерий — неинвазивный маркер изменения сосудистой стенки, легко определяемый при помощи дуплексного сканирования сонных артерий. В статье рассматриваются данные международных исследований, подтверждающих значение ТИМ как предиктора выявления ишемической болезни сердца и независимого фактора риска развития
сердечно-сосудистых событий
Об авторах
О. В. Гайсёнок
ФГБУ Объединенная больница с поликлиникой Управления делами Президента РФ
Государственный научно-исследовательский центр профилактической медицины Минздравсоцразвития России
Россия
Россия
С. Ю. Марцевич
Государственный научно-исследовательский центр профилактической медицины Минздравсоцразвития России
1-й МГМУ им. И.М. Сеченова
Россия
Россия
Список литературы
1. Оганов Р.Г., Масленникова Г.Я. Сердечно-сосудистые заболевания в Российской Федерации во второй половине столетия: тенденции, перспективы. Кардиология 2000;(4):4–8.
2. Wilson P.W., D’Agostino R.B., Levy D., et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837–47.
3. Assmann G., Cullen P., Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Münster (PROCAM) study. Circulation 2002;105:310–5.
4. Conroy R.M., Pyörälä K., Fitzgerald A.P., et al.; SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24(11):987–1003.
5. Khot U.N., Khot M.B., Bajzer C.T., et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2003;290:898–904.
6. Law M.R., Wald N.J., Morris J.K. The performance of blood pressure and other cardiovascular risk factors as screening tests for ischemic heart disease and stroke. J Med Screen 2004;11:3–7.
7. Greenland P. Improving risk of coronary heart disease: can a picture make the difference? JAMA 2003;289:2270–2.
8. Sachdeva A., Cannon C.P., Deedwania P.C., et al. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. Am Heart J 2009;157(1):111–7.
9. Бойцов С.А. Клинические и новые факторы риска сердечно-сосудистых заболеваний. Актуальные вопросы болезней сердца и сосудов 2009;4(4):41–8.
10. Диагностика и лечение артериальной гипертензии. Рекомендации Российского медицинского общества по артериальной гипертонии и Всероссийского научного общества кардиологов. Кардиоваскулярная терапия и профилактика 2008;6(Прил 2):3–32.
11. Mancia G., De Backer G., Dominiczak A., et al.; The task force for the management of arterial hypertension of the European Society of Hypertension, The task force for the management of arterial hypertension of the European Society of Cardiology. 2007 Guidelines for the management of arterial
12. hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007;28:1462–536.
13. Lim T.K., Lim E., Dwivedi G., et al. Normal value of carotid intima-media thickness — a surrogate marker of atherosclerosis: quantitative assessment by B-mode carotid ultrasound. J Am Soc Echocardiogr 2008;21(2):112–6.
14. Ludwig M., von Petzinger-Kruthoff A., von Buquoy M., et al. Intima media thickness of the carotid arteries: early pointer to arteriosclerosis and therapeutic endpoint (in German). Ultraschall Med 2003;24(3):162–74.
15. Pitt B., Byington R.P., Furberg C.D., et al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigatiors. Circulation 2000;102:1503–10.
16. Matsuoka H. STONE study and INSIGHT study: efficacy of nifedipine in the prevention of cardiovascular disease in hypertensive patients. Drugs 2006;66 Spec No 1:13–5.
17. Gariepy J., Simon A., Chironi G., et al. Large artery wall thickening and its determinants under antihypertensive treatment: the IMT-INSIGHT study. J Hypertens 2004;22(1):137–43.
18. Shimokawa H. ACTION study: efficacy of nifedipine in preventing cardiovascular disease in patients with coronary artery disease. Drugs 2006;66 Spec No 1:10–2.
19. Lichtlen P.R., Hugenholtz P.G., Rafflenbeul W., et al. Retardation of coronary artery disease in humans by the calcium-channel blocker nifedipine: results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy). Cardiovasc Drugs Ther 1990;4 (Suppl 5):1047–68.
20. Hedblad B., Wikstrand J., Janzon L., et al. Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: Main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS). Circulation 2001;103(13):1721–6.
21. Crouse J.R. 3rd, Raichlen J.S., Riley W.A., et al. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA 2007;297(12):1344–53.
22. Nissen S.E., Nicholls S.J., Sipahi I., et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006;295(13):1556–65.
23. Holaj R., Spacil J., Petrasek J., et al. Intimamedia thickness of the common carotid artery is the significant predictor of angiographically proven coronary artery disease.Can JCardiol2003;19(6):670–6.
24. Kablak-Ziembicka A., Przewlocki T., Tracz W., et al. Carotid intima-media thickness in pre- and postmenopausal women with suspected coronary artery disease. Heart Vessels 2008;23(5):295–300.
25. Kablak-Ziembicka A., Przewlocki T., Tracz W., et al. Diagnostic value of carotid intima-media thickness in indicating multi-level atherosclerosis. Atherosclerosis 2007;193(2):395–400.
26. Coskun U., Yildiz A., Esen O.B., et al. Relationship between carotid intima-media thickness and coronary angiographic findings: a prospective study. Cardiovasc Ultrasound 2009;7:59.
27. Adams M.R., Nakagomi A., Keech A., et al. Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease. Circulation 1995;92(8):2127–34.
28. Delacr taz E., Fleisch M., Kaufmann U.P., et al. Coronary and peripheral artery remodeling in patients undergoing PTCA: An intracoronary and transcutaneous ultrasound study. Catheter
29. Cardiovasc Interv 1999;48(1):12–7.
30. Teragawa H., Kato M., Kurokawa J., et al. Usefulness of flow-mediated dilation of the brachial artery and/or the intima-media thickness of the carotid artery in predicting coronary narrowing in patients suspected of having coronary artery disease. Am J Cardiol 2001;88(10):1147–51.
31. Sinha D.P., Das M., Banerjee A.K., et al. Comparative study to assess whether high sensitive C-reactive protein and carotid intima media thickness improve the predictive accuracy of exercise stress testing for coronary artery disease in perimenopausal women with typical angina. J Indian Med Assoc 2008;106(2):86, 88, 90 passim.
32. Heiss G., Sharrett A.R., Barnes R., et al. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 1991;134(3):250–6.
33. Chambless L.E., Heiss G., Folsom A.R., et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987–1993. Am J Epidemiol 1997;146:483–94.
34. O'Leary D.H., Polak J.F., Wolfson S.K. Jr., et al. Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke 1991;22(9):1155–63.
35. O'Leary D.H., Polak J.F., Kronmal R.A., et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999;340:14–22.
36. Bots M.L., Hoes A.W., Koudstaal P.J., et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997;96(5):1432–7.
37. Stein J.H., Johnson H.M. Carotidintimamedia thickness, plaques, and cardiovascular disease risk. J Am Coll Cardiol 2010; 55:1608–10.
38. Touboul P.J., Hernandez-Hernández R., Kucukoglu S., et al.; PARC-AALA Investigators. Carotid artery intima media thickness, plaque and Framingham cardiovascular score in Asia, Africa/Middle East and
39. Latin America: the PARC-AALA study. Int J Cardiovasc Imaging 2007;23:557–67.
40. van der Meer I.M., Bots M.L., Hofman A., et al. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Circulation 2004;109:1089–94.
41. Dijk J.M., van der Graat G., Bots M.L., et al. Carotid intima-media thickness and the risk of new vascular events in patients with manifest atherosclerotic disease: the SMART study. Eur Heart J 2006;24:1971–8.
42. Kitagawa K., Hougaku H., Yamagami H., et al. Carotid intima-media thickness and risk of cardiovascular events in high-risk patients. Results of the Osaka Follow-Up Study for Carotid Atherosclerosis 2 (OSACA2 Study). Cerebrovasc Dis 2007;24(1):35–42.
43. Chan S.Y., Mancini G.B., Kuramoto L., et al. The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. J Am Coll Cardiol 2003;42:1037–43.
44. Cicorella N., Zanolla L., Franceschini L., et al. Usefulness of ultrasonographic markers of carotid atherosclerosis (intima-media thickness, unstable carotid plaques and severe carotid stenosis) for predicting presence and extent of coronary artery disease. J Cardiovasc Med (Hagerstown) 2009;10(12):906–12.
45. Cicero A.F., Dormi A., D'Addato S., et al. From risk factor assessment to cardiovascular disease risk and mortality modification. The first 40 years of the Brisighella Heart Study. J Clin Lipidol 2011;6(3):269–76.
46. Kannel W.B., Dawber T.R., Kagan A., et al. Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. Ann Intern Med 1961;55:33–50.
Рецензия
Для цитирования:
Гайсёнок О.В., Марцевич С.Ю. ТОЛЩИНА ИНТИМА-МЕДИА — ПРЕДИКТОР ВЫЯВЛЕНИЯ ИШЕМИЧЕСКОЙ БОЛЕЗНИ СЕРДЦА И НЕЗАВИСИМЫЙ ФАКТОР РИСКА РАЗВИТИЯ СЕРДЕЧНО-СОСУДИСТЫХ СОБЫТИЙ. Клиницист. 2011;5(4):5-9. https://doi.org/10.17650/1818-8338-2011-4-5-9
For citation:
Gaisenok O.V., Martsevich S.Yu. THE THICKNESS OF THE INTIMA-MEDIA — A PREDICTOR OF CORONARY HEART DISEASE AND INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR EVENTS. The Clinician. 2011;5(4):5-9. (In Russ.) https://doi.org/10.17650/1818-8338-2011-4-5-9
Просмотров: 1093
Послать статью по эл. почте 